Core Laboratories N.V. (CLB) Position Lifted by JPMorgan Chase & Co.

JPMorgan Chase & Co. increased its holdings in shares of Core Laboratories N.V. (NYSE:CLB) by 14.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 935,695 shares of the oil and gas company’s stock after acquiring an additional 121,553 shares during the period. JPMorgan Chase & Co. owned approximately 2.12% of Core Laboratories worth $91,904,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Sustainable Growth Advisers LP grew its holdings in Core Laboratories by 36.9% in the second quarter. Sustainable Growth Advisers LP now owns 2,345,271 shares of the oil and gas company’s stock valued at $237,505,000 after purchasing an additional 632,263 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in Core Laboratories by 141.7% in the third quarter. Bank of New York Mellon Corp now owns 567,306 shares of the oil and gas company’s stock valued at $55,992,000 after purchasing an additional 332,620 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC grew its holdings in Core Laboratories by 19.0% in the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 2,025,357 shares of the oil and gas company’s stock valued at $199,904,000 after purchasing an additional 323,357 shares during the last quarter. WCM Investment Management CA grew its holdings in Core Laboratories by 7.3% in the second quarter. WCM Investment Management CA now owns 4,433,175 shares of the oil and gas company’s stock valued at $448,948,000 after purchasing an additional 303,073 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its holdings in Core Laboratories by 1,087.6% in the third quarter. Ameriprise Financial Inc. now owns 315,556 shares of the oil and gas company’s stock valued at $31,143,000 after purchasing an additional 288,985 shares during the last quarter.

Several research firms have weighed in on CLB. BidaskClub lowered Core Laboratories from a “sell” rating to a “strong sell” rating in a report on Monday, August 14th. Zacks Investment Research lowered Core Laboratories from a “hold” rating to a “sell” rating in a report on Tuesday, September 26th. Cowen set a $100.00 target price on Core Laboratories and gave the company a “hold” rating in a report on Friday, October 6th. Royal Bank Of Canada restated a “buy” rating on shares of Core Laboratories in a research report on Wednesday, October 18th. Finally, Piper Jaffray Companies set a $97.00 price objective on Core Laboratories and gave the company a “hold” rating in a research report on Monday, October 23rd. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the stock. Core Laboratories currently has a consensus rating of “Hold” and a consensus price target of $108.64.

Shares of Core Laboratories N.V. (NYSE CLB) opened at $104.50 on Tuesday. The company has a debt-to-equity ratio of 1.53, a current ratio of 2.18 and a quick ratio of 1.81. Core Laboratories N.V. has a 12-month low of $86.55 and a 12-month high of $125.83. The stock has a market capitalization of $4,637.24, a price-to-earnings ratio of 57.40 and a beta of 1.56.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Monday, October 23rd. The oil and gas company reported $0.48 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.44 by $0.04. Core Laboratories had a return on equity of 52.89% and a net margin of 12.06%. The business had revenue of $166.20 million for the quarter, compared to the consensus estimate of $160.94 million. During the same period in the prior year, the business earned $0.38 earnings per share. The business’s revenue was up 1.4% on a year-over-year basis. sell-side analysts anticipate that Core Laboratories N.V. will post 1.99 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 21st. Investors of record on Friday, October 20th were given a dividend of $0.55 per share. The ex-dividend date of this dividend was Thursday, October 19th. This represents a $2.20 annualized dividend and a yield of 2.11%. Core Laboratories’s dividend payout ratio (DPR) is presently 126.44%.

WARNING: This report was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another website, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this report can be accessed at https://www.com-unik.info/2017/12/05/core-laboratories-n-v-clb-position-lifted-by-jpmorgan-chase-co.html.

Core Laboratories Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)

What are top analysts saying about Core Laboratories N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Core Laboratories N.V. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit